Cellaïon

Promethera

The company develops stem cell therapies to treat severe liver diseases for patients suffering from acute-on-chronic liver failure and other end-stage liver conditions.

Clade Therapeutics

This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.

Cellergy Therapeutics

This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.

Altos Labs

This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.

Cellino

The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.

Resolution Therapeutics

Resolution Therapeutics develops macrophage cell therapies to treat patients with inflammatory and fibrotic diseases such as end-stage liver disease.

Theratome Bio

This company develops stem-cell secretome therapeutics to treat ischemic brain injury, dry eye disease and organ transplant preservation for healthcare providers and patients.

TiGenix

This biopharmaceutical company develops allogeneic stem cell therapies to treat patients with inflammatory and autoimmune conditions, such as Crohn's disease.